| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |